Gene Expression Systems and Recombinant Protein Purification by Kishwar Hayat & Khan *
ISSN: 0975-8585 
November - December 2014  RJPBCS   5(6)  Page No. 450 
Research Journal of Pharmaceutical, Biological and Chemical 
Sciences 
 
Gene Expression Systems and Recombinant Protein Purification. 
 
Kishwar Hayat Khan*.  
 





There is no substance as important as deoxyribonucleic acid as it carries within its own structure the 
hereditary in formations that determines the structure of proteins, the important molecule of life. 
Deoxyribonucleic acid transcribe messenger ribonucleic acid which finally translates protein the essential 
macromolecules. Through gene expression the information contained in gene can be utilized for the synthesis 
of functional gene product which is often a protein or an enzyme required for the cellular function of live 
organisms. This article discusses about the various strategies required for the expression of gene to get gene 
product. It also highlighted few expression systems required to express gene. The author also explained the 
strategies regarding the purification of expressed proteins. In this context protein affinity tags were explored 
and highlighted. This review suumarized the role of His-tag, GST-tag, MBP-tag, IMPACT, TAP-Tagging towards 
protein purification. The aim of writing this review article is to attract those researchers working in the field of 
gene expression and protein purification to find new molecules for better therapy. 
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INTRODUCTION 
 
One of the most important scientific legacies that our generations will handover to the successors is 
the detailed and elaborated information about biological sequences and structure now being determined and 
achieved. Deoxyribonucleic acid (DNA), the genetic material, is a long unbranched polymer having the four 
deoxynucleoside monophosphate namely deoxyadenosine monophosphate (dAMP), deoxythymidine 
monophosphate (dTMP), deoxyguanosine monophosphate (dGMP) and deoxycytidine monophosphate 
(dCMP). Nucleic acid is a biological molecule essential for life as it encodes for protein. Proteins are the major 
functional molecules of life whose properties are so useful that we employ them as therapeutic agents, 
catalysts and materials. Many diseases stem from mutation in proteins that cause them to loose function. In 
some cases, catalytic activity may be impaired, and so metabolic pathways may be altered. The example is 
phenylketonaria. In other cases , structural properties may be impaired, leading to a loss of physical function 
as seen in the case of muscular dystrophy. The ultimate goal of protein science is to be able to predict the 
structure and activity of a protein de novo and how it will bind to ligand. When this is achieved, we will be able 
to design and synthesize novel catalyst, materials, and drugs that will eliminate disease and minimize ill 
health[1]. 
 
Genetic engineering has revolutionized protein science. First recombinant DNA technology has 
enabled the production of large quantities of proteins that were previously either unknown or valuable only in 
small quantities. Second it has allowed rapid sequencing of proteins from their DNA. Third it has allowed the 
facile modification of protein structure by mutation of their genes. This has lead to protein engineering. 
Protein engineering is of fundamental importance in analyzing structure function relationships in proteins and 
producing novel proteins for biomedical and biotechnological use.  
 
A gene is defined as a discrete unit of genetic information that can be utilized for the synthesis of 
polypeptide. It includes the coding sequence, the promoter, terminator and introns[2]. In protein production 
there are two aspects which require optimization that is the biology of the system and the production process 
itself.  In order to express a gene in an efficient manner, the gene has to be inserted into an appropriate vector 
containing a suitable promoter. This can then be transferred into a suitable host using the modern technology.  
 
Now a days a variety of vectors as well as expression systems are available to express gene of interest. 
This article is totally based on literature survey. This article has been compiled by the author by using modern 
and traditional methods of literature survey. The search engines used in the survey were Science direct, 
PubMed, Google etc. In addition to this the author also took the help of books and journals for making this 
manuscript. The literatures cited in this article are not limited to a particular region but is considered more or 
less from the entire globe. Recent research has been focused by this author. Literatures for the past ten years 
were paid more attention. Moreover the valuable literatures were also efficiently highlighted in this 
manuscript. 
 
In his previous articles the author highlighted a number of vectors that can be used in gene 
manipulation[3]. In addition to this the author in his another article has described a number of gene transfer 
technologies that can manipulate gene in plants[4]. Prior to this work the author of this article has reported 
about the technologies related to transgenic animals[5]. He also described DNA vaccine [6][7]. In this article 
the author summarized the systems used in expressing gene. He also explored and presented the technologies 
that can be used to purify proteins..The author described the expression of genes in various systems like 
bacteria, yeast, insect and mammals.  Much effort was given to the proteins affinity tag that makes the 
purification step easy and improves the purity and stability of recombinant protein. The aim of writing this 
article is to help the new researchers who are approaching the technology of gene expression and protein 
purification to prepare the products having high therapeutic values for living beings. A number of systems have 
been described below that can be used for the expression of gene. The main objective of this review article is 
to make awareness in the young researchers about the systems used to express gene and to purify the 
expressed protein. 
 
Systems Utilized For Gene Expression 
 
Expression is defined as transcription and translation of gene. The primary goal of gene cloning for 
biotechnological application is the expression of cloned gene in selected host organisms. For commercial 
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purposes, a high rate of production of the protein encoded by cloned gene is required. In order to achieve this, 
many specialized expression vectors have been constructed that provide genetic element for controlling 
transcription, translation, protein stability and secretion of the product of the cloned gene from the host cell. 
The molecular biological features that have been manipulated to modulate gene expression  include the 
promoter and terminator sequences, the strength of ribosome binding site, the number of copies of cloned 
gene etc. The level of foreign gene expression also depends on the host organisms. Currently both prokaryotes 
and eukaryotes expression systems are available for gene expression.  
 
To elevate protein expression it is important that an inducible expression system must be established 
so to enable the growth of large number of host cells before initiating the expression of a target protein[8]. 
The researchers made a report of gene expression in plant by Agrobacterium tumefaciens using green 
fluorescent reporter gene[9]. The author in this article presented a detailed study of a number of systems like 
bacteria, insect, yeast and mammals to express gene to obtain its product. 
 
Bacteria as an expression system 
 
Because of high knowledge about the genetics, biochemistry amd molecular biology, E.coli is the 
system of first choice for expression of genes to get required heterologous proteins. This is because the 
genetic manipulations are straight forward and easy. E coli is easy to culture and the growth is also 
inexpensive. Morever many foreign proteins are well tolerated and may be expressed at high level. Small 
cytosolic proteins and polypeptide less than hundred nucleotide in length are best expressed in E.coli as fusion 
proteins composed of carrier sequences linked by a standard peptide bond to the target protein. If only small 
quantities of the target proteins are required as in the case of screening a series of site directed mutants for 
enzymatic activity. There is little point in trying to optimize production. Most of the standard expression 
plasmids can be used successfully if the enzyme can be assayed in crude extract of E.coli. If the target protein is 
to be used in biochemical or cell biological studies, then maintaining or restoring protein function is important 
and ease of purification matters less. In some cases, direct expression vectors may be used to produce soluble, 
active proteins. In most cases, however, the expressed protein will be insoluble and must be purified from the 
inclusion bodies, solubilized, and refolded into an active form[10].  
 
The uptodate research and development in the fundamental understanding of phenomenon of 
transcription, translation, and protein folding in E. coli and the indirect discoveries and the availability of 
modern genetic tools are further making E.coli more important than ever for the expression of complex 
eukaryotic proteins[11]. The advantages of using E. coli as an expression system is that it produce large 
amount of protein. Moreover the growth of this bacterium is very fast as compared to mammalian cells, giving 
the opportunity to purify, analyze and use the expressed protein in a much shorter time period. In addition to 
this minimal amount of DNA is required to transform E coli cells and transformation experiment is also easy.   
 
The E. coli T7 system is regarded as the most widely used system for high-level gene expression. In 
contrast to other E. coli expression systems using host RNA polymerases for heterologous gene expression, an 
appropriate T7 system yields higher protein amounts since the bacteriophage RNA polymerase exhibits 
enhanced processivity. For this reason, the E. coli T7 expression system has been recently recommended by 
leading structural genomics consortia as a ‘what to try first’ system for the expression of soluble, globular and 
stably folded pro- and eukaryotic proteins[12]. 
 
Recently the researchers reported the expression and purification of chimeric peptide comprising 
EGFR B-cell epitope and measles virus fusion protein T-cell epitope in E. coli [13]. Recombinant expression, 
purification and characterization of the native glutamate racemase from Lactobacillus plantarum NC8 was also 
described
14
. High-level expression, purification, and characterization of Staphylococcus aureus dihydroorotase 
(PyrC) as a cleavable His-SUMO fusion was explained
15
. High expression of HPV16L2N120E7E6 fusion protein in 
E. coli and its inhibitory effect on tumor growth in mice was also studied by the researchers[16]. Moreover the 
researchers also reported on the production of pentameric cholera toxin B subunit in E.coli[17]. The 
researchers studied the over-production of soluble protein complex and validating protein-protein interaction 
through a new bacterial co-expression system[18]. A novel T7 RNA polymerase-dependent expression system 
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Yeast as an expression systems 
 
Yeast belongs to both microorganism and eukaryote and so have the advantages over the other 
expression system. The main reason for selecting yeast as an expression system is that unlike E. coli, yeast 
provides advanced protein folding pathways for heterologous proteins. In addition to this when yeast signal 
sequences are utilized then yeast can easily secrete correctly folded and processed proteins. The proteins can 
be released into the culture media. Moreover simple growth media is the requirement for the growth and 
multiplication of yeast.  
 
The production of protein through recombinant DNA route utilizes Saccharomyces cerevisiae as the 
most favoured microbial eukaryotes. A number of other yeast like Hansela polymorpha,  Schizosaccharomyces 
pombe, Kluveromyces lactis. Pichia pastoris  and Yarrouvia lipolytica are also used for the same purpose. Unlike 
bacteria the proteins expressed in yeast are subjected to post translational modification. In addition to this, 
there is usually a higher degree of authenticity with respect to three dimensional confirmation and the 
immunogenic properties of the protein. Thus, in a situation where the biological properties of the protein are 
critical, yeast may provide a better product than prokaryotic hosts. A variety of strong constitutive promoters 
have been utilized to carry on target gene expression in yeast. The examples in this context are the promoters 
for the genes encoding phosphoglycerate kinase (PGK), glyceraldehyde-3-phosphate dehydrogenase (GPD) and 
alcohol dehydrogenase (ADH1). All of these can be used to produce target proteins[20]. 
 
Pichia pastoris is the most frequently used yeast system for heterologous protein production 
today[21].  A yeast-based rapid prototype platform for gene control elements in mammalian cells was 
reported[22]. Fibronectin C-terminal heparin-binding domain could be expressed and purified successfully in 
Pichia pastoris[23]. Systematic analysis of a dipeptide library for inhibitor development using human dipeptidyl 
peptidase IV produced by a Saccharomyces cerevisiae expression system were performed[24].  Purified 
recombinant Japanese encephalitis virus (JEV) envelope protein expressed in the P. pastoris expression system 
holds great promise for use in the development of a subunit vaccine against JEV[25]. 
 
Expression of gene in insect cells 
 
Baculovirus infect insects and does not appear to infect mammalian cells. Therefore any system based 
on such viruses has the immediate attraction of low risk of human infection because of their colligative nature. 
Baculovirus expression systems are considered important as they posses the ability to produce large amount 
of proteins 
 
Baculoviruses belong to a large group of circular double stranded DNA viruses. This virus infect only 
invertebrates, usually insects[26]. The virus has its genome which is 90-180 kbp[27]. The cell lysis takes place 
after three to five days of initial infection. The nuclear polyhedrosis viruses produce occlusion bodies in the 
nucleus of infected cells. These occlusion bodies consist primarily of protein. High level of polyhedron gene is 
transcribed in the late transfection process[2]. To express the target gene the polyhedron promoter can be 
easily utilized. The Autographa californica nuclear polyhedrosis virus (AcNPV) which is an example of 
baculovirus has become a famous tool to make recombinant protein particularly in insect cells[28] . The 
advantage of protein production in baculovirus infected insect cells is that it produces very high levels of 
protein relative to other eukaryotic expression systems[29][30]. In this system multiple genes can be 
expressed from a single virus. The disadavantge is that the cells grow slowly and the media is inexpensive. 
Moreover the construction and purification of recombinant baculovirus vectors for the expression of target 
genes in insect cells can take four to six weeks which is a long time. In addition to this chance of contamination 
of culture is also there. The main demerit of this system is that the expression of the target protein is 
controlled by a very late viral promoter and peaks when the cells are dying due to the infection from virus[31].   
 
Insect cells have been reported as a production platform of complex virus-like particles[32]. High- 
level expression of neutrophil gelatinase-associated lipocalin lipocalin2 by baculovirus expression was 
reported[33]. The researchers engineered the baculovirus genome in order to produce galactosylated 
antibodies in lepidopteran cells[34]. Insect cell-based expression and characterization of a single-chain variable 
antibody fragment directed against blood coagulation factor VIII were also studied[35]. Moreover expression 
of recombinant human IFNa-2b/IgG4 Fc fusion protein in a baculovirus insect cell system were also 
explained[36]. 
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Mammalian expression system 
 
Mammalian cell expression has become the dominant recombinant protein production system for 
clinical applications because of its capacity for post-translational modification and human protein-like 
molecular structure assembly[37]. In mammalian expression systems the protein, or complex, can be 
expressed in its native cell type, under physiological conditions, with numerous molecular systems working 
together for efficient production and quality control[38]. 
 
As compared to bacteria and other microbes, mammalian expression system is a better system as far 
as recombinant human protein is concerned. Growth media are more expensive and complex. Mammalian 
cells are generally less robust as compared to microbes when large scale fermentation is involved. Difficulties 
are also there for processing of the products. Despite these difficulties, a variety of vectors are now present to 
express protein in mammalian cells. Vectors possess selectable markers and also utilizes promoters that 
enable expression of the cloned gene sequence[2]. The commonly used promoters  are based on 
cytomegalovirus (CMV) or simian virus (SV40). The proteins obtained in mammalian system have the best 
structural and functional features that are usually most close to their cognate native form. It can satisfy the 
applications, needs or utility. The author did the extensive literature survey and finally summarized the 
proteins in table 1. 
 
Viral- based vectors for gene expression in mammalian cells are listed in the table 2.  




Figure 1: Diagramatic representation of transfection by calcium chloride co precipitation method: (A) DNA of interest is 
inserted into plasmid. (B) Vector containing the insert is introduced into   eppendorf containing the transfection buffer. 
(C) Calcium chloride is released slowly to form fine precipitate. (D) Fine precipitate is then allowed to enter into 
mammalian cells (E) Expression of protein. 
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Figure 2: Diagrammatic representation introduction of DNA into cells using cationic liposomes: A) Gene of required 
interest B) Gene is ligated into an appropriate vector C) The vector DNA containing the insert gets surrounded by 
cationic liposomes forming liposome DNA complex. D) Cationic liposomes are able to interact with the negatively 
charged cell membrane resulting in the delivery of DNA across the membrane. The DNA escape endosome mediated 
degradation and gets integrated into the DNA present in the nucleus. E) mRNA gets transcribed F) Protein is then 
formed. 
 
Table 1: Proteins produced by mammalian expression systems and their importance 
 
S.No Application, needs and utility of proteins 
produced by mammalian expression 
system. 
Protein References 
1. Therapeutic application Factor VII, 
Indoleamine 2,3-dioxygenase 
(IDO). 











2. Diagnostic application Monoclonal antibody [46] 
3. Pathology studies Recombinant pigment 
epithelium-derived factor 
[47] 
4. Cell line development Mcl-1 [48] 
5. Drug target discovery Human IgMs [49] 
6. Transgene expression ceramide transfer protein 
(CERT) 
[50] 
7. Prophylactic (vaccine) development HeLa based cell substrate [51] 
8. Immunogen for antibodies development HBsAg antigen [52] 
9.. Protein-protein interaction. experiments Glutathione-S-transferase [53] 
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Table2: Vectors based on virus used for gene transfer in mammalian cell lines 
 
S.No Vectors S.No Vectors 
1. Retroviruses 2. Poliovirus 
3. Epstein-barr virus 4. Adenovirus 
5. Herpes simplex virus 6. Simian virus 40 
7. Sindbis virus 8. Baculovirus 
9. Lentiviruses 10. Semliki forest virus 
11. Adeno-associated virus 12. Vaccinia virus 
 
Enhanced expression of secretable influenza virus neuraminidase in suspension mammalian cells was 
studied[57]. Rapid, simple and high yield production of recombinant proteins in mammalian cells using a 
versatile episomal system was reported[58]. The researchers reported about the different matrix attachment 
regions flanking a transgene, effectively enhance gene expression in stably transfected Chinese hamster ovary 
cells[59].  High level expression, purification and activation of human dipeptidyl peptidase I from mammalian 
cells was also reported[60]. High levels of human recombinant cyclooxygenase-1 expression in mammalian 




The development of techniques and methods for the separation and purification of biological 
macromolecules such as proteins has been an important prerequisite for many of the advancement made in 
bioscience and biotechnology over the past five decades. Improvement in materials, utilization of 
computerized instruments, and an increase use of invivo tagging have made proteins separations more 
predictable and controllable. In recent years the success of genomics has provided the impetus to explore and 
understand the molecular events that happens within the cell. The genome provides the information to 
manufacture a protein, but it provides non of the information on the activity or function of that protein once it 
has been synthesized in the cell. 
 
The main aim of protein analysis and purification is to elucidate its structure and function. The 
purification of protein is a multistep process. It utilizes biochemical and biophysical characteristics of the target 
protein, such as its source, relative concentration, solubility, charge and hydrophobicity. The ideal purification 
strives to obtain the maximum recovery of the desired protein, with minimal loss of activity, combined with 
the maximum removal of other non-target proteins. The methods applied for protein purification must be mild 
to protect and preserve the native conformation of the molecule and its bioactivity. One should aim the 
following as listed in the Table 3 while designing the purification protocol for protein.  
 
Table 3: Factors to be considered during protein purification 
 
S,No Key considerations during protein purification 
1. Purification step should be simple. The number of steps involved should be kept as minimium as possible. 
2. Process should be cheap. Expensive technique shouls be avoid or replace with cheap techniques. Reagent 
used must be cheap. 
3. Recovery must be high 
4. Assays are developed to monitor the purification. 
5. End product must be highly purified. 
6. Process must be convenient with regard to time. 
7. Reproducibility within the lab, in other labs and also when either scaled up or down. 
8. A notice will be kept on yields and activity throughout 
9. Reliable techniques and apparatus must be used 
10. Delay and slow equipment must be avoided 
 
 
There is an increasing requirement for biological scientists of all disciplines (at all levels) to be able to 
device protocols to enrich a low abundance protein for subsequent analysis. The two important parameters 
utilized to develop most purification protocols are the physical properties and the chemical structure of the 
protein. Charge density, isoelectric points (PI), PH stability are some of the properties of proteins that can be 
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exploited during purification. A number of techniques are now available that are capable of resolving protein 
on the basis of differences in net charge. These include gel electrophoresis and ion exchange chromatography.  
 
Various affinity procedure to purify protein is listed in the table 4. 
 
Table 4: Affinity procedure for purifying protein 
 
S.No Affinity procedure 
1. Affinity chromatography 
2. Covalent chromatography 
3. Dye legand affinity chromatography 
4. Immobilized metal (ion) affinity chromatography (IMAC) 
5. Immunoaffinity chromatography 
6. Lectin affinity chromatography 
7. IMAC for purifying recombinant protein 
8. Affinity partitioning (Precipitation) 
 
 
Protein stability is a crucial issue in biotechnology. The most potentially useful protein is of little value 
if cannot be produced, isolated, and stably stored. It is often difficult to purify recombinant proteins. The 
purification will require multiple time-consuming chromatographic steps to get an acceptable level of purity. 
Now a day to make protein purification easy the researchers were taking the help of protein tags.  These tags 
are protein sequences. These sequences exhibit high affinity binding properties for particular molecules. The 
main function of the tag is that it allows the target protein to bind to a solid support, usually in the form of a 
column matrix, to which very few (if any) other proteins are able to bind. A number of steps are envolved for 
the purification of tagged proteins from host cells. Initially the host cell is allowed to lyse.  Then the tagged 
proteins are allowed to bind to an affinity column. Untagged proteins are then removed by washing. Then the 
tagged protein was eluted out.  A number of tag proteins are now available to make the purification of 
recombinant protein a convenient procedure. 
 
The Glutathione S-Transferase-tag 
 
 This is also an important tag used in protein purification. Glutathione comprises of glutamic acid, 
glycine and cysteine. The enzyme Glutathione-S-transferace (GST) binds to glutathione with greater affinity. 
The gene responsible for encoding this protein is fused in the correct reading frame, to the target gene and a 
fusion protein is produced from an expression vector. The host cells making the fusion protein are then 
observed. The cells producing the protein are lysed. The soluble proteins are then applied to a column 
containing glutathione (eg glutathione-agarose). The specific interaction between GST and glutathione take 
place. It helps in the binding of the fusion protein to the column. Most of the proteins remain unbound to the 
column. The bonded protein can then be eluted by washing with a high concentration of glutathione to 
compete for the interaction with the column. The GST portion then can be removed from the fusion 
protein[2].  
Table 5: Recognition and cleavage site of protease 
 
S.No Protease Recognition and cleavage site References 
1. PreScission LeuGluValLeuPheGlnGlyPro [62] 
2. Factor Xa IleGluGlyArg [63] 
3. TEV GluAsnLeuTyrPheGlnGly [64] 
4. Enterokinase AspAspAspAspLys [65] 
5. Thrombin LeuValProArgGlySer [66] 
 
 To make this goal possible, an appropriate expression vector is first selected.  DNA segment that has 
the capability of coding the amino acid sequence of a specific protease cleavage site is to be introduced 
between the GST and the target gene placed in an expression vector. The protein is then expressed. The 
expressed purified protein is treated with protease. This causes the formation of two polypeptides. One 
peptide will be free target protein and other will be GST itself. To separate the target protein from GST, it is 
again applied to the glutathione column. The GST will again bind to the column, but the target protein will not. 
The column flow through can be eluted and will contain the purified target protein. Several specific protease 
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have been used to cleave target fusion protein obtained by using purification tags. A number of these 
proteases with recognition and cleavage site have been listed in the Table 5.  
 
 Reports were made regarding the E.coli expression system and baculovirus-insect cell expression 
system that were used to produce the kinase, followed by purification using His-tag[67].  Researchers also 
described the method to purify soluble LubX protein using GST-tag and E. coli overexpression systems[68].  
Studies were also made regarding Human PNAS-4 (hPNAS-4) which is a novel pro-apoptotic protein in 
mammalian cells. The hPNAS-4 gene was first cloned into the pGEX-6p-1 vector with GST tag. The recombinant 
hPNAS-4 was then purified[69].   
 
The Maltose Binding Protein tag 
 
The bacteria E.coli posses a gene known as malE gene. This gene encodes maltose binding protein 
(MBP). The expression vector uses this gene for protein purification purpose. In an expression vector the target 
gene is inserted downstream from the malE gene of E. coli. This results in the production of an MBP fusion 
protein[70]. One step purification of fusion protein is done using the affinity of MBP for cross linked 
amylase[71]. The target protein get bound to the column of amylase and eluted with maltose. The MBP-target 
fusion is cleaved with a protease. It is again applied to the amylase column. The protein of interest will not get 
attached to the column and thus get separated from MBP. 
 
The MBP tag was used in concerned with expression, purification and characterization of non-specific 
Serratia nuclease in E. coli[72]. Expression of proteins in E. coli as fusions with maltose-binding protein to 
rescue non-expressed targets in a high-throughput protein-expression and purification was also reported[73].  
Elevated solubility of integrin beta A domain by using maltose-binding protein as a fusion tag was 
described[74]. Mitochondrial fraction of apoptotic cells contains membrane protein called as p18Bax.  




          Affinity tags are highly efficient tools that can be used for protein purification. These tags permit the 
purification of virtually any type of protein without having any prior knowledge of its biochemical properties. 
These affinity tags have wide applications in several areas of research. The simplest among all the protein tag 
used for protein purification is the Histidine tag (His tag). This tag comprises of six histidine residues. For every 
protein it is the DNA that codes for it.  The DNA for the histidine residue is cloned into the target gene. The 
cloning is performed in such a way that the produced protein contains at some point in its polypeptide 
sequence, six consecutive histidine residues[76]. During the time of cloning the His tag is placed either at the 
extreme amino or extreme carboxyl-terminal end of the protein so that it is less likely to impair the function of 
protein. If the central region of the protein is already recognized to be non-essential, then the tag can be 
placed in the middle of the protein[77].  Certain metal ions are available with which histidine can bind  non-
covalently and with high affinity. Nickel is the metal ions that are bound to a resin matrix and are used to 
capture protein containing his tag[78]. To achieve the above aim the most commonly used resins have 
nitrocellulose acid (NTA) covalently attached to them. The NTA has four coordination sites that bind very 
tightly a single nickel ion. At least six histidine residues are needed to provide the necessary binding affinity to 
firmly adhere the tagged protein to the column. The other protein will not bind to the column and were eluted 
out leaving behind the tagged protein attached to the column. The tagged proteins were finally eluted by 
changing the concentration of buffer used in elution process[2]. 
 
 The recombinant L -arabinose isomerase was purified to homogeneity by one-step His-tag affinity 
chromatography was described[79]. Expression and purification of human PYY(3-36) in E. coli using a His-
tagged small ubiquitin-like modifier fusion was also reported[80]. His-tag truncated butyrylcholinesterase as a 
useful construct for in vitro characterization of wild-type and variant butyrylcholinesterases was described[81]. 
The researchers also reported about histidine-tag-directed chromophores for tracer analyses in the analytical 
ultracentrifuge[82]. His-tag was also used to study the expression and purification of recombinant human 
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Tandem-affinity purification tag 
 
The reason behind the popularity of affinity tags is that considerable purification can be performed in 
just a single chromatography step. To achieve the desired purity a single step is usually not sufficient. Dual 
affinity tags have been developed in the recent years in which two different affinity tags are expressed in 
tandem. This method was originally developed in yeast and is called tandem affinity purification (TAP) [83]. 
TAP tagging systems, developed by the research group of Bertrand Seraphin and others, are a means of 
isolating physiologically relevant protein and protein-nucleic acid complexes[84]. This tag facilitates fast 
purification of complexes from a relatively small number of cells. The purification takes place without prior 
information of the complex composition, activity or function[85][86]. The purification procedure consists of 
two steps. It is highly specific and can isolate contaminant-free protein complexes. At the 3-end of a target 
gene, the DNA Tap -tag is cloned so that little disruption is made to its ability to be transcribed, and the fusion 
protein should be produced at the same level as the wild-type target protein. The Tap-tag encodes a 
calmodulin binding peptide and protein A from Staphylococcus aureus. These two are separated from each 
other by a TEV protease cleavage site[87]. Tagged protein containing cells were lysed. It is then applied to a 
column containing IgG, which binds with greater affinity to protein A. The fusion protein and its associated 
proteins are removed from the column using TEV protease and then applied directly to a calmodulin bead 
column, in the presence of Ca
2+
 and eluted using chelating agent like EDTA.  
 
The researchers reported about in vivo investigation of protein-protein interactions for helicases using 
TAP[88]. The TAP method is an efficient system for protein complex purification and protein interaction 
identification[89]. Moreover an enhanced strategy for TAP-tagging of Schizosaccharomyces pombe genes was 
sttudied[90]. Reports were also made regarding the targeted TAP of PSD-95 recovers core postsynaptic 
complexes and schizophrenia susceptibility proteins[91]. The studies were also made in concwerned with a 
modified version of TAP tagging to identify proteins interacting with HIV-1 Rev in human[92]. The author listed 
various  in the Table 6. 
Table 6: Tag used for purification purpose. 
 
S.No Tag S.No Tag 
1. Avi Tag 2. V5tag 
3. Xpress tag 4. Isopep tag 
5. HA-tag 6. Nus-tag 
7. Spytag 8. Thioredoxin-tag 
9. S-tag 10. TC tag 
11. Ty tag 12. Strep-tag 
13. SBP-tag 14 Green fluorescent protein-tag 
15 Myc-tag 16 Calmodulin-tag 
17 Softag 3 18 Softag 1 
19 FLAG-tag 20 BCCP tag 
 
Intein-mediated purification with an affinity chitin binding tag 
 
The use of protein fusion and affinity technology has simplified the purification of recombinant 
proteins. Intein-mediated purification with an affinity chitin binding tag are also used by the researchers for 
protein purification. It is also known as  IMPACT.   Inteins are proteins.  They are present in a number of 
organisms, which excise themselves from a precursor protein and in the process, ligate the flanking protein 
sequences[93]. IMPACT uses the protein self splicing of inteins to remove the purification tag and give pure 
isolated protein in single chromatographic steps. Most inteins have asparagine at their carboxyl terminal and a 
cystine residue at their amino terminal end. All the information required for the splicing reaction is stored 
within the intein itself, and if these sequences are placed in the context of target protein they still splice 
themselves out. An expression vector is taken to which the target gene is cloned such that a three component 
fusion protein is obtained, in which a target protein inteinchitin binding domain fusion protein is 
produced. 
 
 E.coli is the microorganism that is used nn IMPACT system and fusion protein is made in the said 
microrganism. For protein purification a chitin column is made. The fusion protein is passed through this 
column. The protein will bind the chitin column.  Dithiothreitol (DTT) can be used to cleave off the protein 
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from the column at 4 C. The process is slow and so it required overnight incubation to complete. This is 
problematic if the target protein is not stable under these conditions. The target protein produced by this 
method is native except for DTT thioester moiety attached at the carboxyl terminal end. This thioester is 
unstable. It will hydrolyse to yield native protein.  
 
 The researchers reported Intein-mediated expression, purification, and characterization of thymosin 
α1-thymopentin fusion peptide in E. coli[94]. Intein-mediated one-step purification of E. coli secreted human 
antibody fragments was also studied[95]. By using the intein-mediated purification with a affinity chitin 
binding tag system, the peptide thioester M-[A(49)]-SDF-1(1-49)-MESNA was expressed[96]. Using IMPACT 




The main conclusion is that the author made a systemic study on various expression system. The 
reader can know through this article about the gene to be expressed. More over a concise study has been 
represented regarding protein purification. A number of protein purification tags were also described by the 
author which can make the purification step easy. It is the requirement of the present time to discover new 
expression system that can express and yield protein without damaging its biological properties. The system 
should be designed in such a way so that it should be less time consuming and also require less effort. The 
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